NCT01316380 - Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma | Biotech Hunter

Enrollment

465

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Asthma

Interventions

DRUG

placebo

To evaluate efficacy and safety of 2.5 and 5 mcg tiotropium versus placebo delivered via Respimat inhaler

DRUG

tiotropium 2.5 mcg

To evaluate efficacy and safety of 2.5 and 5 mcg tiotropium versus placebo delivered via Respimat inhaler

DRUG

tiotropium 5 mcg

To evaluate efficacy and safety of 2.5 and 5 mcg tiotropium versus placebo delivered via Respimat inhaler

Trial Locations (62)

Unknown

205.442.54002 Boehringer Ingelheim Investigational Site, Capital Federal

205.442.54005 Boehringer Ingelheim Investigational Site, Capital Federal

205.442.54003 Boehringer Ingelheim Investigational Site, San Juan Bautista

205.442.43002 Boehringer Ingelheim Investigational Site, Linz

205.442.43003 Boehringer Ingelheim Investigational Site, Schlüsslberg

205.442.43001 Boehringer Ingelheim Investigational Site, Wels

205.442.38502 Boehringer Ingelheim Investigational Site, Rijeka

205.442.38501 Boehringer Ingelheim Investigational Site, Split

205.442.38503 Boehringer Ingelheim Investigational Site, Split

205.442.38504 Boehringer Ingelheim Investigational Site, Zagreb

205.442.37203 Boehringer Ingelheim Investigational Site, Kohtla-Järve

205.442.37201 Boehringer Ingelheim Investigational Site, Rakvere

205.442.37202 Boehringer Ingelheim Investigational Site, Tartu

205.442.50203 Boehringer Ingelheim Investigational Site, Guatemala City

205.442.50204 Boehringer Ingelheim Investigational Site, Guatemala City

205.442.50201 Boehringer Ingelheim Investigational Site, Nivel Guatemala

205.442.50202 Boehringer Ingelheim Investigational Site, Nivel Guatemala

205.442.50205 Boehringer Ingelheim Investigational Site, Vila Hermosa I

205.442.36007 Boehringer Ingelheim Investigational Site, Budapest

205.442.36003 Boehringer Ingelheim Investigational Site, Cegléd

205.442.36002 Boehringer Ingelheim Investigational Site, Gödöllö

205.442.36004 Boehringer Ingelheim Investigational Site, Komárom

205.442.36006 Boehringer Ingelheim Investigational Site, Pécs

205.442.36001 Boehringer Ingelheim Investigational Site, Szarvas

205.442.36005 Boehringer Ingelheim Investigational Site, Százhalombatta

205.442.91011 Boehringer Ingelheim Investigational Site, Ahmedabad

205.442.91005 Boehringer Ingelheim Investigational Site, Bangalore

205.442.91009 Boehringer Ingelheim Investigational Site, Banglore

205.442.91002 Boehringer Ingelheim Investigational Site, Coimbatore

205.442.91003 Boehringer Ingelheim Investigational Site, Coimbatore

205.442.91004 Boehringer Ingelheim Investigational Site, Coimbatore

205.442.91008 Boehringer Ingelheim Investigational Site, Hyderabad

205.442.91007 Boehringer Ingelheim Investigational Site, Jaipur

205.442.91001 Boehringer Ingelheim Investigational Site, Nagpur

205.442.91006 Boehringer Ingelheim Investigational Site, Pune

205.442.39007 Boehringer Ingelheim Investigational Site, Acquaviva Delle Fonti (BA)

205.442.39006 Boehringer Ingelheim Investigational Site, Cagliari

205.442.39003 Boehringer Ingelheim Investigational Site, Chieti

205.442.39001 Boehringer Ingelheim Investigational Site, Pisa

205.442.37101 Boehringer Ingelheim Investigational Site, Baldone

205.442.37103 Boehringer Ingelheim Investigational Site, Daugavpils

205.442.37104 Boehringer Ingelheim Investigational Site, Daugavpils

205.442.37102 Boehringer Ingelheim Investigational Site, Talsi

205.442.48003 Boehringer Ingelheim Investigational Site, Giżycko

205.442.48002 Boehringer Ingelheim Investigational Site, Gorzów Wielkopolski

205.442.48005 Boehringer Ingelheim Investigational Site, Krakow

205.442.48004 Boehringer Ingelheim Investigational Site, Ostrow Wielkopolska

205.442.48001 Boehringer Ingelheim Investigational Site, Poznan

205.442.42105 Boehringer Ingelheim Investigational Site, Bardejov

205.442.42107 Boehringer Ingelheim Investigational Site, Humenné

205.442.42104 Boehringer Ingelheim Investigational Site, Košice

205.442.42102 Boehringer Ingelheim Investigational Site, Nitra

205.442.42101 Boehringer Ingelheim Investigational Site, Nové Zámky

205.442.42108 Boehringer Ingelheim Investigational Site, Poprad

205.442.42106 Boehringer Ingelheim Investigational Site, Spišská Nová Ves

205.442.42103 Boehringer Ingelheim Investigational Site, Topoľčany

205.442.82006 Boehringer Ingelheim Investigational Site, Cheongju-si

205.442.82002 Boehringer Ingelheim Investigational Site, Gangwon-do

205.442.82001 Boehringer Ingelheim Investigational Site, Seoul

205.442.82003 Boehringer Ingelheim Investigational Site, Seoul

205.442.82004 Boehringer Ingelheim Investigational Site, Seoul

205.442.82005 Boehringer Ingelheim Investigational Site, Seoul